Clinical Trials in Fuencarral-El Pardo, Spain
2 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Phase 2
CRF2 Agonist for the Treatment of Worsening Heart Failure
Worsening Heart Failure
Corteria Pharmaceuticals300 enrolled43 locationsNCT06815471
Recruiting
Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
CancerDepressionAnxiety
Fundación Sociedad Española de Oncologia Médica540 enrolled18 locationsNCT07168096
Recruiting
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Leukemia, Acute Lymphoblastic
Mats Heyman500 enrolled53 locationsNCT03911128
Recruiting
Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry
Atrial Fibrillation
Fundación EPIC234 enrolled22 locationsNCT06620757